Related stories
BCP Investment Agrees to Acquire Investcorp Credit Management BDC
M impact | EQUITY | Nov 11, 2026, 11:12 PM UTC
Vylor Reports Q3 2026 Revenue of $938 Million, Reaffirms Guidance
Revenue was $938 million, above FactSet estimates of $922.9 million. Adjusted pro forma operating loss was $0.42 per share, better than the $0.58-per-share consensus loss. Vylor re
M impact | EQUITY | Nov 11, 2026, 11:02 PM UTC
Global market picture: S&P 500 +0.99%, Nasdaq 100 +1.46%; EUR/USD -0.68%, WTI +0.42%
Global market picture. US index futures: S and P futures is up 0.99 percent, Nasdaq futures is up 1.46 percent, Dow futures is up 0.65 percent and Russell futures is up 0.7 percent
M impact | EQUITY | Nov 11, 2026, 11:02 PM UTC
WSJ Reports Nvidia Board Is Preparing to Oust CEO Jensen Huang
The Wall Street Journal reports that Nvidia’s board is preparing to oust Huang over two extramarital affairs. The report says there is no clear succession plan.
M impact | EQUITY | Nov 11, 2026, 10:53 PM UTC
WSJ: Nvidia Board Preparing to Oust CEO Jensen Huang
The Wall Street Journal reported that Nvidia’s board is preparing to oust founder and CEO Jensen Huang. Directors could meet as soon as Wednesday to determine his future, the repor
M impact | EQUITY | Nov 11, 2026, 10:51 PM UTC
MoonLake Immunotherapeutics Shares Climb Roughly 8% Ahead of FDA Filing Deadline
MoonLake Immunotherapeutics shares rose roughly 8% on Wednesday as investors focused on an upcoming FDA acceptance deadline for its lead drug filing, sonelokimab.
M impact | EQUITY | Nov 11, 2026, 10:51 PM UTC